Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05948696
Other study ID # AF007
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 6, 2023
Est. completion date September 29, 2023

Study information

Verified date July 2023
Source TsaoTun Psychiatric Center, Department of Health, Taiwan
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Taiwan National Health Insurance Administration database shows that the number of people seeking medical treatment due to mental illness has reached 1.454 million in 2021. The annual growth rate of mental illness is between 3.3% to 6.6%. Fifty percent of mental illness patient has catastrophic illness certificate because of chronic schizophrenia (Ministry of Health and Welfare,2022). Auditory hallucinations, delusions, emotional disturbances, and disorder in behavior and the poor ability of speaking are common in patients with schizophrenia. These symptoms lead to reduce the cognitive and executive function, resulting severe impairment of eventual daily living functions and social interactions. Thus, the cost of hospitalization and medical fee is increased. It is worth considering the appropriateness of the model of care. According to researches, people with schizophrenia still strive to pursue a happy and satisfying life. However, statistics of satisfaction and happiness are still lower than people who are healthy (Palmer et al., 2014; Fervaha et al., 2016). The American Horticultural Therapy Association (AHTA) pointed out that horticultural therapy increases the well-being of participants through active or passive participation in plant-related activities. It also helps participants learn new skills or regain lost skills. Furthermore, psychiatric symptoms, recovery outcomes, life satisfaction, and the benefits of social function are significantly improved (Lu et al., 2021; Oh et al., 2018). Taiwanese scholars mention that combining horticultural activities and group psychotherapy improves the therapeutic results. It means that using of flowers and plants in gardening combines with the therapeutic advantages of group psychotherapy, mental illness patients can benefit more from it (Lin, 2016). This study aims to explore the experience of patients with chronic schizophrenia participating in horticultural group therapy. This research design adopts the purposive sampling in qualitative method from a psychiatric hospital in central Taiwan. It is expected that 10 participants will involve in 12 times of horticultural therapy, and recordings will be made in each group. After 12 times of the therapy, participants will be involved in semi-structured audio-recorded interviews. The collected data were analyzed step by step using the content analysis method. In addition, participants will finish the questionnaires of the "Mental Well-Being Scale"," Satisfaction With Life Scale ", " activity of daily living Scale ", Instrumental Activities of Daily Living Scale", and "Group Efficacy Observation Form" before and after the therapies. The data will be conducted with descriptive statistics, Pearson's correlation coefficient, Chi-square Test, Paired Sample t test by using SPSS 21.0 statistical software. This research hopes to understand the impact of horticultural treatments in people who suffer from chronic schizophrenia, and provides a reference to clinical teams.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date September 29, 2023
Est. primary completion date September 6, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Persons with schizophrenia and have been hospitalized to for more than 6 months. - Intact or minimal cognitive performance on SPMSQ. - Mild to moderate severity on Brief Psychiatric Rating Scale. - ADL score>65 on Barthel Index - Moderate or low on the Warwick-Edinburg Mental Well-being scale Exclusion Criteria: - Those who are not able to comply with the requirements of the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Horticultural group therapy.
Estimated 10 persons with schizophrenia who attend to a 12-week horticultural group therapy will be assessed for their experience about the program.

Locations

Country Name City State
Taiwan TsaoTun Psychiatric Center Nantou

Sponsors (1)

Lead Sponsor Collaborator
TsaoTun Psychiatric Center, Department of Health, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Group Efficacy Measured by Group Efficacy Observation Form 12 weeks
Primary Well-being Measured with the Warwick-Edinburg Mental Well-being scale 12 weeks
Secondary Basic and instrumental activities of daily living 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT00161044 - An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms N/A
Completed NCT01450514 - POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia Phase 2
Completed NCT05809882 - Study of Experience of High-frequency Repetitive Transcranial N/A
Completed NCT06206798 - Resourcefulness Group Intervention on Recovery and Quality of Life N/A
Completed NCT01761383 - Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia N/A
Completed NCT01891929 - Cognitive Remediation and Sheltered Employment in Schizophrenia N/A
Completed NCT03275909 - Integrated Psychological Therapy for Chronic Schizophrenia N/A
Completed NCT02298985 - Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients Phase 4
Recruiting NCT00525863 - Oxygen Therapy in Schizophrenia Phase 3
Completed NCT02624167 - A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia Phase 2
Completed NCT00789698 - Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia Phase 3
Recruiting NCT06349369 - Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia N/A
Completed NCT02421146 - The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study N/A
Active, not recruiting NCT00664274 - Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia N/A
Terminated NCT00148616 - Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia Phase 3